We are live on ! Find out more
GCTK icon

GlucoTrack
GCTK

2 hedge funds and large institutions have $74K invested in GlucoTrack in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

9% more capital invested

Capital invested by funds: $68K → $74K (+$6K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AF
Alerus Financial
North Dakota
+$26K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boston Financial Management
Massachusetts
$51K – – –
AF
2
Alerus Financial
North Dakota
$23K +$26K +2 New

GCTK Hedge Fund Activity: Q3 2022 in Review

2 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q3 2022, worth a combined $74K — up 8.8% from $68K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new GCTK positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Alerus Financial, opening a new position worth an estimated $26K.

  • 2 institutional investors held GlucoTrack (GCTK) as of Q3 2022, up from 1 in Q2 2022.
  • Funds reported $74K of GlucoTrack stock for Q3 2022, up 8.8% quarter-over-quarter.
  • 1 fund opened new GlucoTrack positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest GlucoTrack buyer in Q3 2022 was Alerus Financial, an estimated $26K added.

Based on aggregated 13F filings for Q3 2022.